| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Poisoning by mitomycin |
Causative agent (attribute) |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Accidental mitomycin poisoning |
Causative agent (attribute) |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
|
| Intentional mitomycin poisoning |
Causative agent (attribute) |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
|
| intoxication par la mitomycine d'intention indéterminée |
Causative agent (attribute) |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Mitomycin adverse reaction |
Causative agent (attribute) |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to mitomycin |
Causative agent (attribute) |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
|
| Mitomycin overdose |
Causative agent (attribute) |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Accidental mitomycin overdose |
Causative agent (attribute) |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Intentional mitomycin overdose |
Causative agent (attribute) |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| surdose de mitomycine d'intention indéterminée |
Causative agent (attribute) |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
|
| Mitomycin 2 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
|
| Mitomycin 20mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
|
| Mitomycin 5mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
|
| Mitomycin 40mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
|
| Product containing mitomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Mitomycin 20 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
|
| Subconjunctival administration of mitomycin |
Direct substance |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Accidental mitomycin poisoning |
Causative agent (attribute) |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Intentional mitomycin poisoning |
Causative agent (attribute) |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Subconjunctival administration of mitomycin |
Direct substance |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Instillation of mitomycin C into urinary bladder |
Direct substance |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Instillation of mitomycin C into urinary bladder |
Direct substance |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to mitomycin |
Causative agent (attribute) |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Mitomycin 20 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Mitomycin 20 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Mitomycin 2 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Mitomycin 2 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing mitomycin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Mitomycin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only mitomycin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely mitomycin 40 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely mitomycin 40 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely mitomycin 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely mitomycin 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Mitomycin 5 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Mitomycin 5 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release intravesical solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release intravesical solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only mitomycin in intravesical dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing mitomycin in intravesical dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Subconjunctival administration of mitomycin to left eye (procedure) |
Direct substance |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Subconjunctival administration of mitomycin to bilateral eyes (procedure) |
Direct substance |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Subconjunctival administration of mitomycin to bilateral eyes (procedure) |
Direct substance |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
2 |
| Subconjunctival administration of mitomycin to right eye |
Direct substance |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Trabeculectomy with intraoperative administration of mitomycin |
Direct substance |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
| Trabeculectomy of right eye with intraoperative administration of mitomycin |
Direct substance |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
2 |
| Trabeculectomy of left eye with intraoperative administration of mitomycin |
Direct substance |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
2 |
| Trabeculectomy of bilateral eyes with intraoperative administration of mitomycin (procedure) |
Direct substance |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
3 |
| Mitomycin intravascular chemoembolization of cornea |
Using substance (attribute) |
True |
Mitomycin (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]